ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0347

Longitudinal ANA Titers in SLE and ANA+ Controls

Emily Littlejohn1, Lingxuan Kong2, Kelly Speth2, Lu Wang2 and Emily Somers2, 1Cleveland Clinic, Cleveland, OH, 2University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2021

Keywords: ANA, Autoantibody(ies), longitudinal studies, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Session Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Antinuclear or anticellular antibodies (ANAs), are a hallmark of systemic lupus erythematosus (SLE). ANAs are also a marker of subclinical autoimmunity, with ~13% of the general adult population ANA+. Risk factors for developing subclinical autoimmunity are poorly understood. An important step is to understand trajectories of ANA positivity and titers within individuals over time. We performed an exploratory analysis of electronic health record (EHR) data to assess intraindividual variation in ANAs longitudinally.

Methods: Utilizing our academic health center’s EHR we formed a sub-cohort of all patients with at least 2 ANA tests (by immunofluorescence, IFA). A titer of ≥1:80 was considered positive. We evaluated the effect of time on the titer value using a longitudinal random effect model comparing across different patient groups defined by ICD codes: (1) ANA-associated rheumatic diseases (Sjogren’s Syndrome, dermatomyositis, polymyositis, scleroderma, undifferentiated connective tissue disease, mixed connective tissue disease); (2) ANA+ controls without rheumatic disease; (3) SLE. A subset of SLE was validated by a rheumatologist and fulfilled ACR/SLICC criteria (4).

Results: 7226 patients had at least two valid ANA-IFA lab results (SLE by ICD n=1706, validated SLE n=54, alternate rheumatic diagnosis n=1644, ANA+/no rheumatic diagnosis n=3822). Of 5603 patients with a positive ANA at the first observation, 4 (7%) of SLE and 953 (17.2%) of non-SLE and had a subsequent negative ANA. Longitudinally, the strength of ANA titer changed over time (p< 0.001) among both SLE and non-SLE patients. Controlling for time, SLE patients had a higher odds of a positive ANA titer on average vs non-SLE [OR 1.44, 95% CI (1.19, 1.75)]. SLE patients also had a higher odds ratio on average of a positive ANA titer associated with time change compared to non-SLE [ratio of OR overtime 1.09, 95% CI (1.02, 1.17), p< 0.001].

Conclusion: While previous cross-sectional data have shown that ANAs tend to increase with age, longitudinal data of intra-individual patterns are lacking. Our data provide initial evidence of intra-individual variability over time, with SLE patients having increasing titers over time. Future work includes investigating demographic and other covariates to discern titers in SLE and non-SLE ANA+ clinical phenotypes. We seek to determine if pre-clinical (or subclinical) periods are opportunities for intervention to modify the course of autoimmunity and clinical progression.

Longitudinal trajectory of average ANA titers over the order of measurement across 4 different groups of patients.


Disclosures: E. Littlejohn, Aurinia Pharmaceuticals, 6; L. Kong, None; K. Speth, None; L. Wang, None; E. Somers, None.

To cite this abstract in AMA style:

Littlejohn E, Kong L, Speth K, Wang L, Somers E. Longitudinal ANA Titers in SLE and ANA+ Controls [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/longitudinal-ana-titers-in-sle-and-ana-controls/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-ana-titers-in-sle-and-ana-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences